loading

Inovio Pharmaceuticals Inc (INO) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
100.00%
-
0.0653 0.1008 - 0.1027
Operating Expenses
8.09%
23.08
25.12 33.30 31.48 27.50
Benefits Costs and Expenses
-
- - - 25.11
Costs And Expenses
8.09%
23.08
25.12 33.30 31.48 25.11
Operating Income/Loss
7.85%
-23.08
-25.05 -33.20 -31.48 -27.39
Income/Loss From Continuing Operations Before Tax
19.42%
-23.52
-19.69 0.1008 -30.47 -25.00
Income/Loss From Continuing Operations After Tax
19.42%
-23.52
-19.69 -32.24 -30.47 -24.97
Net Income/Loss
19.42%
-23.52
-19.69 -32.24 -30.47 -25.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Diluted Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Basic Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Diluted Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.23
price down icon 0.68%
$92.90
price down icon 0.29%
$28.92
price up icon 0.96%
$104.39
price up icon 0.46%
biotechnology ONC
$312.02
price up icon 0.74%
$182.66
price down icon 3.82%
大文字化:     |  ボリューム (24 時間):